KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Deferred Tax Assets (2016 - 2025)

Historic Current Deferred Tax Assets for Pfizer (PFE) over the last 16 years, with Q3 2025 value amounting to $3.9 billion.

  • Pfizer's Current Deferred Tax Assets rose 1887.14% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 1887.14%. This contributed to the annual value of $3.3 billion for FY2024, which is 1669.18% down from last year.
  • Latest data reveals that Pfizer reported Current Deferred Tax Assets of $3.9 billion as of Q3 2025, which was up 1887.14% from $4.0 billion recorded in Q2 2025.
  • Over the past 5 years, Pfizer's Current Deferred Tax Assets peaked at $4.3 billion during Q4 2021, and registered a low of $2.5 billion during Q4 2022.
  • For the 5-year period, Pfizer's Current Deferred Tax Assets averaged around $3.5 billion, with its median value being $3.6 billion (2022).
  • Per our database at Business Quant, Pfizer's Current Deferred Tax Assets plummeted by 3438.23% in 2022 and then surged by 5397.01% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Current Deferred Tax Assets stood at $4.3 billion in 2021, then fell by 16.15% to $3.6 billion in 2022, then grew by 11.21% to $4.0 billion in 2023, then dropped by 16.69% to $3.3 billion in 2024, then increased by 16.32% to $3.9 billion in 2025.
  • Its Current Deferred Tax Assets was $3.9 billion in Q3 2025, compared to $4.0 billion in Q2 2025 and $2.9 billion in Q1 2025.